“Low Levels of HER2 Expression: New Ideas for Differentiated Strategies in the Choice of Treatment for Triple-Negative Breast Cancers”. Voprosy Onkologii, vol. 69, no. 1, Mar. 2023, pp. 38-44, https://doi.org/10.37469/0507-3758-2023-69-1-38-44.